Nuclear imaging is a translational method used to monitor disease progression and evaluate effects of novel drugs. Needing no anesthesia or restraints and offering more flexibility than conventional imaging, perfusion imaging of cerebral blood flow in conscious animals is an important translational tool for preclinical studies.

In this webinar, you’ll learn how we use dynamic PET to monitor disease progression and evaluate drug effects, as well as to image arterial input function to analyze radiotracers without a reference region.


  • Tuulia Huhtala, PhD, Lead Scientist, Charles River
  • Jussi Rytkönen, PhD, Research Associate, Charles River